Stocks and Investing Stocks and Investing
Fri, November 13, 2020
Thu, November 12, 2020
Wed, November 11, 2020
Tue, November 10, 2020
Mon, November 9, 2020

Steve Chesney Downgraded (BIIB) to Sell and Held Target at $175 on, Nov 9th, 2020


Published on 2024-10-27 14:42:01 - WOPRAI, Steve Chesney
  Print publication without navigation


Steve Chesney of Atlantic Equities, Downgraded "Biogen Inc." (BIIB) to Sell and Held Target at $175 on, Nov 9th, 2020.

Steve has made no other calls on BIIB in the last 4 months.



There are 7 other peers that have a rating on BIIB. Out of the 7 peers that are also analyzing BIIB, 5 agree with Steve's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Colin Bristow of "UBS" Initiated at Hold and Held Target at $268 on, Wednesday, October 28th, 2020
  • Salim Syed of "Mizuho" Maintained at Hold with Decreased Target to $282 on, Tuesday, October 27th, 2020
  • Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $244 on, Thursday, October 22nd, 2020
  • Christopher Raymond of "Piper Sandler" Maintained at Hold with Decreased Target to $265 on, Tuesday, October 20th, 2020
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $277 on, Friday, September 18th, 2020


These are the ratings of the 2 analyists that currently disagree with Steve


  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $350 on, Thursday, October 22nd, 2020
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $357 on, Thursday, October 22nd, 2020